Trust & Fiduciary Management Services’s AstraZeneca AZN Stock Holding History

Trust & Fiduciary Management Services’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-1,202	Closed	-$78K	–	46
2014 Q1	$78K	Buy	1,202 +385	+47%	+$24.9K	0.04%	67
2013 Q4	$49K	Sell	817 -85	-9%	-$4.62K	0.03%	69
2013 Q3	$47K	Hold	902	–	–	0.04%	74
2013 Q2	$43K	Buy	+902	New	+$45.9K	0.03%	72

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

MCM

Mason Capital Management New York $607M AUM 1.77% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Trust & Fiduciary Management Services's AZN Position: Q2 2014 in Review

Trust & Fiduciary Management Services sold out of AstraZeneca (AZN) in Q2 2014, closing a stake of 1,202 shares — an estimated $78K sold.

Trust & Fiduciary Management Services first reported a position in AZN in Q2 2013 and held it in 4 quarters. The position peaked at $78K in Q1 2014. 419 funds tracked by Wall St. Rank hold AZN as of Q2 2014.

Trust & Fiduciary Management Services reported no remaining AstraZeneca position as of Q2 2014 after selling out during the quarter.
Trust & Fiduciary Management Services sold 1,202 AstraZeneca shares in Q2 2014, an estimated $78K.
Trust & Fiduciary Management Services first reported a position in AstraZeneca in Q2 2013 and held it in 4 quarters.
Trust & Fiduciary Management Services's AstraZeneca position peaked at $78K in Q1 2014.
419 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2014.

Based on Trust & Fiduciary Management Services's 13F filing for Q2 2014, filed 8 Aug 2014.